Cleo Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
Cleo Diagnostics has a total shareholder equity of A$9.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$9.9M and A$486.2K respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$9.37m |
| Equity | AU$9.39m |
| Total liabilities | AU$486.22k |
| Total assets | AU$9.88m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: COV's short term assets (A$9.4M) exceed its short term liabilities (A$486.2K).
Long Term Liabilities: COV has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: COV is debt free.
Reducing Debt: COV had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COV has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: COV has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 62% each year.